Comparative study on signal transduction in endothelial cells after anti-A/B and human leukocyte antigen antibody reaction: Implication of accommodation

Transplantation

Volumn 93, Issue 4, 2012, Pages 390-397

  Iwasaki, Kenta ^a   Miwa, Yuko ^a   Ogawa, Haruko ^b   Yazaki, Satoko ^c,d   Iwamoto, Masaki ^c,d   Furusawa, Tadashi ^d   Onishi, Akira ^d   Kuzuya, Takafumi ^a   Haneda, Masataka ^a   Watarai, Yoshihiko ^e   Uchida, Kazuharu ^e   Kobayashi, Takaaki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c Prime Tech Ltd   (Japan)

^d NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^e NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

ABO incompatible transplantation; Accommodation; Complement regulatory protein; ERK; HLA antibody; Signal transduction pathway

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; HLA ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; COMPARATIVE STUDY; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT INHIBITION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INACTIVATION; FERRITIN H GENE; GENE; HEME OXYGENASE 1 GENE; HUMAN; HUMAN CELL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD55; ANTIGENS, CD59; APOFERRITINS; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIAL CELLS; GRAFT REJECTION; HEME OXYGENASE-1; HLA ANTIGENS; HUMANS; MAP KINASE SIGNALING SYSTEM; ONCOGENE PROTEIN V-AKT; ORGAN TRANSPLANTATION; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION;

EID: 84857062399     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182424df3     Document Type: Article

References (24)

1. WomerKL, Kaplan B. Recent developments in kidney transplantation-A critical assessment. Am J Transplant 2009; 9: 1265.
2. Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: Integrating paired donation into desensitization protocols. Am J Transplant 2010; 10: 449.
3. Jordan SC, Peng A, Vo AA. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients. Contrib Nephrol 2009; 162: 13.
4. Gloor JM, Winters JL, Cornell LD, et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010; 10: 582.
5. Marfo K, Lu A, Ling M, et al. Desensitization protocols and their outcome. Clin J Am Soc Nephrol 2011; 6: 922.
6. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7: 1743.
7. Haas M, Segev DL, Racusen LC, et al. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol 2009; 20: 197.
8. Cornell LD, Smith RN, Colvin RB. Kidney transplantation: Mechanisms of rejection and acceptance. Annu Rev Pathol 2008; 3: 189.
9. Jindra PT, Zhang X, Mulder A, et al. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 2006; 82(1 suppl): S33.
10. Narayanan K, Jendrisak MD, Phelan DL, et al. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Transpl Immunol 2006; 15: 187.
11. Iwasaki K, Miwa Y, Haneda M, et al. Significance of HLA class I antibodyinduced antioxidant gene expression for endothelial cell protection against complement attack. Biochem Biophys Res Commun 2010; 391: 1210.
12. O'Donnell J, Mille-Baker B, Laffan M. Human umbilical vein endothelial cells differ from other endothelial cells in failing to express ABO blood group antigens. J Vasc Res 2000; 37: 540.
13. Zhang X, Reed EF. Effect of antibodies on endothelium. Am J Transplant 2009; 9: 2459.
14. Flevaris P, Li Z, Zhang G, et al. Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood 2009; 113: 893.
15. Bader AG, Kang S, Zhao L, et al. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005; 5: 921.
16. Park WD, Grande JP, Ninova D, et al. Accommodation in ABOincompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003; 3: 952.
17. Grubbs BC, Benson BA, Dalmasso AP. Characteristics of CD59 upregulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement. Xenotransplantation 2003; 10: 387.
18. Griesemer AD, Okumi M, Shimizu A, et al. Upregulation of CD59: Potential mechanism of accommodation in a large animal model. Transplantation 2009; 87: 1308.
19. Dehoux J-P, Gianello P. Accommodation and antibodies. Transplant Immunol 2009; 21: 106.
20. Chang AT, Platt JL. The role of antibodies in transplantation. Transplant Rev 2009; 23: 191.
21. Lindberg L, Johansson SM, Liu J, et al. Is there a clinical need for a diagnostic test allowing detection of chain type-specific anti-A and anti-B? Transfusion 2011; 51: 494.
22. Stewart ZA, Locke JE, Montgomery RA, et al. ABO-incompatible deceased donor liver transplantation in the United States: A national registry analysis. Liver Transpl 2009; 15: 883.
23. Kobayashi T, Maruya E, Niwa M, et al. Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation. Hum Immunol 2011; 72: 11.
24. Colvin RB, Hirohashi T, Farris AB, et al. Emerging role of B cells in chronic allograft dysfunction. Kidney Int Suppl 2010; 119: S13.